Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
THE CLINICAL SPECTRUM OF MICROCYSTIC MACULAR OEDEMA.
[The clinical outcomes of idiopathic optic neuritis with no light perception in 21 eyes].
A case of neuromyelitis optica misdiagnosed as cervicogenic headache.
[Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis].
Activation of NOD2/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo.
The Wnt Effector Transcription Factor 7-Like 2 Positively Regulates Oligodendrocyte Differentiation in a Manner Independent of Wnt/β-Catenin Signaling.
Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy.
Correction: An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy.
Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: Beneficial effects in experimental autoimmune encephalomyelitis.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis.]
Therapeutic Effect of Transplanted Human Wharton's Jelly Stem Cell-Derived Oligodendrocyte Progenitor Cells (hWJ-MSC-derived OPCs) in an Animal Model of Multiple Sclerosis.
The effects of a group-based cognitive behavioral therapy on people with multiple sclerosis: a randomized controlled trial.
[Driving ability with multiple sclerosis.]
Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4.
Multiple sclerosis in the Arabian Gulf countries: a consensus statement.
Role of thalamic diffusion for disease differentiation between multiple sclerosis and ischemic cerebral small vessel disease.
HLA associations in South Asian multiple sclerosis.
P2X Receptors as Drug Targets.
Screening, Synthesis, and In Vitro Evaluation of Vinyl Sulfones as Inhibitors of Complement-Dependent Cytotoxicity in Neuromyelitis Optica.
Vitamin D and the central nervous system.
A case of multiple sclerosis and celiac disease.
Control of Human PLP1 Expression Through Transcriptional Regulatory Elements and Alternatively Spliced Exons in Intron 1.
Neuromyelitis optica in a Ugandan woman: a case report.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.
Pages
« first
‹ previous
…
445
446
447
448
449
450
451
452
453
…
next ›
last »